Overview

To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the long-term safety of arformoterol over a period of 12 months in subjects with COPD
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Formoterol Fumarate
Salmeterol Xinafoate